IRIS
INSERRA, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.460
EU - Europa 1.886
AS - Asia 1.771
SA - Sud America 383
AF - Africa 212
OC - Oceania 6
Totale 7.718
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.358
SG - Singapore 902
RU - Federazione Russa 647
CN - Cina 432
IT - Italia 404
BR - Brasile 324
IE - Irlanda 270
DE - Germania 167
VN - Vietnam 166
UA - Ucraina 130
CI - Costa d'Avorio 102
FR - Francia 95
CA - Canada 86
BD - Bangladesh 61
IN - India 51
GB - Regno Unito 49
KR - Corea 45
SN - Senegal 36
NG - Nigeria 33
SE - Svezia 29
AR - Argentina 26
IQ - Iraq 18
ZA - Sudafrica 16
HK - Hong Kong 14
PL - Polonia 12
ID - Indonesia 11
JP - Giappone 11
ES - Italia 10
FI - Finlandia 10
NL - Olanda 10
TR - Turchia 10
AT - Austria 9
CO - Colombia 9
EC - Ecuador 9
MX - Messico 9
CH - Svizzera 8
PK - Pakistan 8
UZ - Uzbekistan 8
BE - Belgio 6
MA - Marocco 6
AL - Albania 5
AU - Australia 5
ET - Etiopia 5
GR - Grecia 5
KE - Kenya 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
LT - Lituania 4
NP - Nepal 4
SA - Arabia Saudita 4
IL - Israele 3
IR - Iran 3
JM - Giamaica 3
LB - Libano 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CY - Cipro 2
CZ - Repubblica Ceca 2
JO - Giordania 2
MY - Malesia 2
PE - Perù 2
TT - Trinidad e Tobago 2
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 7.718
Salva come PNG Salva come JPEG
Città #
Singapore 519
Santa Clara 459
Dallas 433
Chandler 374
Moscow 296
Dublin 269
San Jose 228
Houston 160
Ashburn 159
Jacksonville 147
Chicago 141
Abidjan 102
Beijing 101
Boardman 101
Bremen 76
Lawrence 76
Cambridge 75
Andover 74
Nanjing 67
Lauterbourg 66
Los Angeles 60
Toronto 53
Catania 50
Des Moines 47
Seoul 45
Grafing 43
Ho Chi Minh City 43
Civitanova Marche 42
Hanoi 37
Dakar 36
Council Bluffs 35
Wilmington 35
New York 30
São Paulo 28
Nanchang 26
Buffalo 21
Saint Petersburg 21
San Mateo 19
Shenyang 19
Frankfurt am Main 17
Civitavecchia 16
The Dalles 16
Orem 15
Abuja 14
Hebei 14
Hefei 14
Kochi 14
Atlanta 13
Columbus 13
Hong Kong 13
Lagos 13
Ottawa 13
Vicenza 13
Jiaxing 12
Montreal 11
Rome 11
Tianjin 11
Tokyo 11
Warsaw 11
Ann Arbor 10
Changsha 10
Phoenix 10
Brasília 9
Dong Ket 9
Johannesburg 9
Manchester 8
Milan 8
Modena 8
Poplar 8
Helsinki 7
Munich 7
Pune 7
Rio de Janeiro 7
San Giuliano Milanese 7
Seattle 7
Baghdad 6
Belo Horizonte 6
Brooklyn 6
Brussels 6
Curitiba 6
Miami 6
Padova 6
Palermo 6
Port Harcourt 6
Aci Catena 5
Chennai 5
Denver 5
Guangzhou 5
Guarulhos 5
Jinan 5
London 5
Messina 5
New Delhi 5
Porto Alegre 5
Shanghai 5
Tirana 5
Amsterdam 4
Asunción 4
Bologna 4
Bắc Ninh 4
Totale 5.139
Salva come PNG Salva come JPEG
Nome #
ASSOCIATION OF IRRITABLE BOWEL SYNDROME WITH NON-EROSIVE REFLUX DISEASE 321
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 192
PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH CELIAC DISEASE IN EASTERN SICILY AREA 185
Arterial stiffness is increased in patients with inflammatory bowel disease 176
Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn's Disease? 172
La Fenoverina nel trattamento della sindrome del colon irritabile 168
CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN INFLAMMATORY BOWEL DISEASE 150
Crohn's disease during pregnancy 148
Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy 144
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 138
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 137
RISK FACTORS OF COLORECTAL POLYPS IN MALE POPULATION OF SOUTH-EASTERN SICILY 135
Alterazioni carotidee in corso di insufficienza renale cronica 134
Gastrointestinal complications after kidney transplantation 134
685 Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 132
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 132
Arterial structure and function in inflammatory bowel disease. 128
Irritable Bowel syndrome: subgroups and relationship with gastroesophageal reflux disease 128
AORTIC-BRACHIAL STIFFNESS MISMATCH STARTS EARLY IN PATIENTS WITH CHRONIC KIDNEY DISEASE 128
A case of osseous metaplasia in the stomach 126
Overlapping of gastroesophageal reflux disease and irritable Bowel syndrome 126
Caso clinico: Una rettorragia in un giovane ragazzo 124
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 123
Uso della mesalazina e del beclometasone dipropionato nella pancolite ulcerosa. Descrizione di un caso clinico 122
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 121
Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis 116
Colorectal Endoscopic Polipectomy: A Retrospective Study 114
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 114
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 113
Arterial stiffness in patients with inflammatory bowel diseases 109
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 108
EVALUATION OF CROHN'S DISEASE ACTIVITY BY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 108
Clinical significance of cytomegalovirus (CMV) infection in inflammatory bowel disease 105
Arterial stiffness is increased in inflammatory bowel disease, dependent upon inflammation and reduced by immunomodulatory drugs 105
Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2 105
Linfoma non-Hodgkin ad esordio digiunale (stadio II E 2). Follow-up a medio termine di un caso trattato con chirurgia e terapia sistemica 100
PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE INCREASED ARTERIAL STIFFNESS 96
A REAL LIFE COMPARISON OF THE EFFECTIVENESS OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTRE EXPERIENCE FROM A REGIONAL NETWORK FOR INFLAMMATORY BOWEL DISEASE 90
Protection By Copper (Cu++) Against Ethanol-Induced Gastric Mucosal Injury In The Rat 89
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 88
La clebopride nel trattamento della dispepsia funzionale: studio clinico in doppio cieco v/s placebo 87
Phenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typing 85
Pepsinogen A, Pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics 84
Su1339 Ulcerative Colitis (UC) Diagnosed Over Age 65 Years -An IG-IBD Study 84
LEWIS ANTIGEN EXPRESSION AND OTHER PATHOGENIC FACTORS IN THE PRESENCE OF ATROPHIC CHRONIC GASTRITIS IN A EUROPEAN POPULATION 83
A propensity score-matched comparison of infliximab and adalimumab in naïve and non-naïve patients with Crohn’s disease 83
Inflammation and aortic stiffness: An individual participant data meta-analysis in patients with inflammatory bowel disease 82
Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs 82
Crohn's disease of the small bowel: evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw index 81
Prevalenza di HHV6 nelle malattie infiammatorie dell’intestino 81
Omeprazole vs. ranitidine in short-term treatment of Helicobacter pylori positive duodenal ulcer patients 81
Hiatal Hernia And Reflux Esophagitis: An Endoscopic Study 80
PREVALENZA DI HHV6 NELLE MALATTIE INFIAMMATORIE DELL’INTESTINO 79
Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study 75
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine. A single-blind randomized controlled trial 75
Subclinical atherosclerosis in patients with inflammatory bowel diseases: A systematic review and meta-analysis 74
Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox 74
Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease 74
Inflammatory bowel diseases and pericarditis 73
P181 Diagnostic performance of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) in the evaluation of stenosis and endoscopic recurrence in Crohn's disease 70
COMPARISON OF ESTIMATING GFR FORMULAS IN ELDERLY 69
OC.02.4 THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): A COMPARISON OF THE EFFICACY OF CURRENT BIOLOGICS IN CROHN'S DISEASE 69
Estimated GFR and renal sinus section area are independent predictors of renal dysfunction in elderly 67
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 65
P.05.22 INFLAMMATORY BOWEL DISEASES AND PERICARDITIS 62
P.05.4 ARTERIAL STIFFNESS IS INCREASED IN IBD PATIENTS 61
P737 SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis 61
P.07.1 ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) ARE LESS LIKELY TO PERSIST ON ANTI-TNF THERAPY COMPARED WITH YOUNGER PATIENTS. DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD) 61
Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study 59
Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study 59
P539 Does a change in therapeutic approach modify outcome in IBD patients? A comparison between two cohorts 2004–2007 and 2010–2013 59
OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS 57
OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety 56
Early anti-tumor necrosis factor therapy reduces aortic stiffness in inflammatory bowel disease: a multicentre longitudinal study 56
Estimation of cardiovascular risk according to asymptomatic organ damage in subjects with inflammatory bowel disease 55
P545 Elderly patients with inflammatory bowel disease (IBD) are less likely to persist on anti-TNF therapy compared with younger patients: data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 54
P412 The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy 53
Totale 7.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022535 64 80 4 15 85 5 80 18 34 1 16 133
2022/20231.037 85 67 25 170 81 171 4 175 223 5 25 6
2023/2024366 23 57 21 12 16 66 19 28 3 7 83 31
2024/20251.613 20 231 97 79 351 215 65 64 144 137 114 96
2025/20263.156 183 78 495 239 486 691 360 59 219 145 108 93
2026/202729 29 0 0 0 0 0 0 0 0 0 0 0
Totale 7.894